Northwest Cancer Specialists

Tigard, Oregon 97223

0 studies enrolling now · 3 studies all time

What they study most

KEAP1 Gene Mutation, Metastatic Castration-Resistant Prostate Cancer, NFE2L2 Gene Mutation, NRF2 Mutation, Non-Small Cell Lung Cancer, Non-Squamous Non-Small Cell Neoplasm of Lung, Non-squamous Non-small-cell Lung Cancer, Triple Negative Breast Cancer

Studies at this site

• XmAb®20717 (Vudalimab) Alone or in Combination With Chemotherapy or Targeted Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer — Completed
• Clinical Trial of Neoadjuvant Chemotherapy With Atezolizumab or Placebo in Patients With Triple-Negative Breast Cancer Followed After Surgery by Atezolizumab or Placebo — Running, not enrolling
• NGS Screening Protocol to Detect Mutation of KEAP1 or NRF2/NFE2L2 Genes for the KEAPSAKE (CX-839-014) Trial — Stopped early